Macpherson IR, Spiliopoulou P, Rafii S, Saggese M, et al. A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer. Breast Cancer Res 2019;22:1.
PMID: 31892325